OLR Bill Analysis
AN ACT CONCERNING PRESCRIPTION DRUG MONITORING.
This bill requires people or institutions that must register with the Department of Consumer Protection (DCP) as controlled substance practitioners to also register for access to DCP's electronic prescription drug monitoring program (see BACKGROUND). They must do so in the manner the DCP commissioner prescribes.
The bill applies to practitioners distributing, administering, or dispensing controlled substances in Connecticut, or proposing to distribute, prescribe, administer, or dispense controlled substances in this state. By law, such practitioners must register with DCP as controlled substance practitioners.
For this purpose, practitioners are: physicians; dentists; veterinarians; podiatrists; optometrists; physician assistants; advanced practice registered nurses; nurse-midwives; scientific investigators; hospitals; or other people or institutions licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to, or administer a controlled substance in the course of professional practice or research in the state.
EFFECTIVE DATE: October 1, 2012
Electronic Prescription Drug Monitoring Program
DCP's electronic prescription drug monitoring program collects and maintains in a central database prescription data for Schedule II through Schedule V controlled substances dispensed by pharmacies and outpatient pharmacies in hospitals or institutions. Information in the database is available to prescribing practitioners and pharmacists in the treatment of their patients.
sHB 5056 (File 92), reported favorably by the General Law Committee, expands the electronic prescription drug monitoring program to include (1) out-of-state pharmacies that send drugs into the state and (2) any other drug dispensing practitioner. It also allows the DCP commissioner to identify additional products to be included in the program.
Public Health Committee